Successor Entity. 38 Section 10.01 Company May Consolidate, Etc..................................................... 38 Section 10.02 Successor Entity Substituted..................................................... 39 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... 39
Appears in 4 contracts
Samples: Pacificare Health Systems Inc /De/, America West Holdings Corp, America West Holdings Corp
Successor Entity. 38 36 Section 10.01 10.01. Company May Consolidate, Etc..................................................... 38 .......................................... 36 Section 10.02 Successor Entity Substituted..................................................... 39 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... 3910.02
Appears in 2 contracts
Samples: Viropharma Inc, Viropharma Inc
Successor Entity. 38 Section 10.01 Company May Consolidate, Etc..................................................... .................................................. 38 Section 10.02 Successor Entity Substituted..................................................... .................................................. 39 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... .................................... 39
Appears in 2 contracts
Samples: Gen Probe Inc, Gen Probe Inc
Successor Entity. 38 Section 10.01 10.1 Company May Consolidate, Etc..................................................... ......................................... 38 PAGE Section 10.02 10.2 Successor Entity Substituted..................................................... ......................................... 39 Section 10.03 10.3 Evidence of Consolidation, Etc. to Trustee....................................... .......................... 39
Appears in 1 contract
Samples: Remedytemp Inc
Successor Entity. 38 Section 10.01 Company May Consolidate, Etc..................................................... ............................................................ 38 Section 10.02 Successor Entity Substituted..................................................... ............................................................ 39 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... .............................................. 39
Appears in 1 contract
Samples: Onyx Pharmaceuticals Inc
Successor Entity. 38 Section 10.01 10.1 Company May Consolidate, Etc..................................................... 38 Section 10.02 10.2 Successor Entity Substituted..................................................... 39 Section 10.03 10.3 Evidence of Consolidation, Etc. to Trustee....................................... ...................................... 39
Appears in 1 contract
Samples: Indenture (Ask Jeeves Inc)
Successor Entity. 38 32 Section 10.01 Company May Consolidate, Etc..................................................... 38 . ................................................. 32 Section 10.02 Successor Entity Substituted..................................................... 39 ................................................... 33 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... 39..................................... 33
Appears in 1 contract
Samples: Bei Technologies Inc
Successor Entity. 38 Section 10.01 Company May Consolidate, Etc..................................................... ........................................... 38 Section 10.02 Successor Entity Substituted..................................................... ........................................... 39 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... ............................. 39
Appears in 1 contract
Samples: Urs Corp /New/
Successor Entity. 38 Section 10.01 Company May Consolidate, Etc..................................................... ............................................................. 38 Section 10.02 Successor Entity Substituted..................................................... ............................................................. 39 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... ............................................... 39
Appears in 1 contract
Samples: Onyx Pharmaceuticals Inc
Successor Entity. 38 Section 10.01 Company May Consolidate, Etc..................................................... ........................................ 38 Section 10.02 Successor Entity Substituted..................................................... ........................................ 39 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... .......................... 39
Appears in 1 contract
Samples: America West Holdings Corp
Successor Entity. 38 32 Section 10.01 Company May Consolidate, Etc..................................................... 38 ............................................... 32 Section 10.02 Successor Entity Substituted..................................................... 39 ............................................... 33 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... 39................................. 33
Appears in 1 contract
Samples: Bei Technologies Inc
Successor Entity. 38 Section 10.01 Company May Consolidate, Etc..................................................... ................................................ 38 Section 10.02 Successor Entity Substituted..................................................... ................................................ 39 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... .................................. 39
Appears in 1 contract
Samples: Myogen Inc
Successor Entity. 38 Section 10.01 Company May Consolidate, Etc..................................................... ............................................. 38 Section 10.02 Successor Entity Substituted..................................................... ............................................. 39 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... ............................... 39
Appears in 1 contract
Samples: Pacificare Health Systems Inc /De/
Successor Entity. 38 Section 10.01 Company May Consolidate, Etc..................................................... ....................................... 38 Section 10.02 Successor Entity Substituted..................................................... ....................................... 39 Section 10.03 Evidence of Consolidation, Etc. to Trustee....................................... ......................... 39
Appears in 1 contract
Samples: America West Holdings Corp
